- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Automatic Translation feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
INCOMPATIBLE RBC TRANSFUSION WITHOUT HEMOLYSIS IN A PATIENT WITH ALLO ANTI-C, -e AND -HI
-
- Sugawara Akiko
- Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University Hospital
-
- Kitsukawa Hisako
- Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University Hospital
-
- Takasaki Minae
- Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University Hospital
-
- Okutsu Miho
- Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University Hospital
-
- Saito Shunichi
- Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University Hospital
-
- Kawabata Kinuyo
- Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University Hospital
-
- Yasuda Hiroyasu
- Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University Hospital
-
- Ohto Hitoshi
- Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University Hospital
-
- Sato Yoshiyuki
- Department of Cardiovascular Surgery, Fukushima Medical University Hospital
-
- Yokoyama Hitoshi
- Department of Cardiovascular Surgery, Fukushima Medical University Hospital
Bibliographic Information
- Other Title
-
- Rh血液型不適合輸血によっても溶血性副作用を呈さなかった抗C+e+HI抗体保有症例
Search this article
Description
Antibodies against Rh antigens have been associated with clinically significant hemolytic transfusion reactions. We describe here the uneventful transfusion of C+e+ red cells to a previously transfused patient with anti-C and anti-e.<br> A 69-year-old male with a wound infection had a history of transfusion one year prior, at which time no alloantibodies were detected. Seven units of concentrated red cells were ordered for debridement surgery. Anti-HI was identified in the patient's plasma, but he required transfusion before antibody screening was complete. Compatibility testing with anti-HI-depleted plasma allowed the release and transfusion of 4 units (2 bags) of red cells. Anti-C and -e were identified after transfusion. Subsequently, 6 units (4 bags) of C- e- red cells were transfused for postoperative hemorrhage. Although the first 4 units of red cells were C+e+, no evidence of hemolysis was observed in 4 months following transfusion.<br> Titers of anti-C+e increased from 1 : 2 on Day 0 to 1 : 4 on Day 30 : however, no hemolysis was observed with this increase. IgG subclasses of anti-C+e could not be identified because of the low titer. While the direct antiglobulin test was negative on Days 5 and 7, panagglutinating antibodies including anti-C+e were eluted from patient's red cells on both 2 days.<br> Anti-C+e titer was low and incompatible blood was partially lost due to perioperative bleeding, so it is plausible that hemolysis was not observed in this situation. Nevertheless, to reduce the likelihood of incompatible transfusion events, it is important to educate physicians about the value of early antibody screening.<br>
Journal
-
- Japanese Journal of Transfusion and Cell Therapy
-
Japanese Journal of Transfusion and Cell Therapy 56 (4), 495-500, 2010
The Japan Society of Transfusion Medicine and Cell Therapy
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390282680249745664
-
- NII Article ID
- 130004542622
-
- ISSN
- 18830625
- 18813011
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed